CBD and Treatment-Resistant Epilepsy: Evidence, Medicines & Safety
Epilepsy is a neurological condition in which some people continue to experience seizures despite appropriate anti-seizure treatment. Cannabidiol has an established role in specific severe epilepsy syndromes when used as an authorised prescription medicine under specialist supervision.
What Clinical Evidence Applies To
Trials of purified pharmaceutical cannabidiol have shown seizure reduction in defined epilepsy syndromes. Observational studies have also examined other standardised CBD preparations, but these designs are less able to establish cause and effect.
Why the Product Matters
Evidence from prescription or standardised medical formulations should not be transferred to ordinary retail CBD oils. Concentration, purity, dosing, monitoring and drug interactions can differ substantially.
Safety and Interactions
CBD can interact with anti-seizure medicines and other drugs. Depending on the treatment combination, clinicians may monitor liver enzymes, sedation, appetite and other adverse effects.
Do Not Change Epilepsy Treatment Without a Specialist
Anyone with epilepsy should not stop, reduce or replace prescribed anti-seizure medication based on a retail CBD article or product. Cannabinoid treatment in epilepsy belongs within specialist medical care.
What This Means in Malta
Prescription cannabinoid medicines and consumer cannabinoid products are not the same category. Retail CBD should not be marketed as an epilepsy treatment.
Key Takeaway
Cannabidiol is medically important in specific epilepsy indications, but the evidence applies to defined medicinal products and clinical supervision. Consumer CBD is not a substitute.
Educational disclaimer: This article is general information and not medical advice.
